Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmunArray has developed blood-based diagnostic tests using its proprietary iCHIP microarray platform. Its SLE-Key test supports diagnosis of systemic lupus erythematosus, while other assays target traumatic brain injury. The company collaborates with leading clinicians in the US and Israel, was a recipient of the GE-NFL Head Health Challenge grant for TBI biomarker research, and continues to expand its product portfolio. Clinical results have demonstrated improved accuracy in diagnosing targeted conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImmunArray.